| Authors: |
Bocobo A; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA., Whitman J; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA., Keenan BP; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA; UCSF Division of Hematology and Oncology, Department of Medicine, San Francisco, CA; UCSF HDFCCC Cancer Immunotherapy Program, San Francisco, CA., Koser KL; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA., Kidder WA; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA; UCSF Division of Hematology and Oncology, Department of Medicine, San Francisco, CA., Piawah S; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA; UCSF Division of Hematology and Oncology, Department of Medicine, San Francisco, CA., Van Loon K; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA; UCSF Division of Hematology and Oncology, Department of Medicine, San Francisco, CA., Behr SC; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA; UCSF Department of Radiology and Biomedical Imaging, San Francisco, CA., Kolli KP; UCSF Department of Radiology and Biomedical Imaging, San Francisco, CA., Chen X; UCSF Clinical Cancer Genomic Laboratory, San Francisco, CA., Onodera C; UCSF Clinical Cancer Genomic Laboratory, San Francisco, CA., Pande M; UCSF Clinical Cancer Genomic Laboratory, San Francisco, CA., Pollak M; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA., Wang R; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA., Babdor J; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA; UCSF Department of Otolaryngology - Head and Neck Surgery and Department of Microbiology & Immunology, San Francisco, CA., Spitzer MH; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA; UCSF Department of Otolaryngology - Head and Neck Surgery and Department of Microbiology & Immunology, San Francisco, CA., Zhang L; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA; UCSF Division of Hematology and Oncology, Department of Medicine, San Francisco, CA; UCSF Department of Epidemiology and Biostatistics, San Francisco, CA., Fong L; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA; UCSF Division of Hematology and Oncology, Department of Medicine, San Francisco, CA; UCSF HDFCCC Cancer Immunotherapy Program, San Francisco, CA., Atreya CE; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC), San Francisco, CA; UCSF Division of Hematology and Oncology, Department of Medicine, San Francisco, CA; UCSF HDFCCC Cancer Immunotherapy Program, San Francisco, CA. Electronic address: chloe.atreya@ucsf.edu. |
